Might losartan reduce sudden cardiac death in diabetic patients with hypertension?

This publication has 19 references indexed in Scilit:

• Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
  The Lancet, 2002
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)
  The Lancet, 1999
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias
  The American Journal of Cardiology, 1994
• Beta-blocker therapy in the cardiac arrhythmia suppression trial
  The American Journal of Cardiology, 1994
• Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect
  The American Journal of Cardiology, 1994
• Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients ≥62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction ≥40%
  The American Journal of Cardiology, 1994
• Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials
  European Heart Journal, 1992
• Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction. Prepared for the Norwegian Multicentre Study Group.
  Circulation, 1982
• A Randomized Trial of Propranolol in Patients With Acute Myocardial Infarction
  JAMA, 1982